Alpha Tau Medical Ltd. (NASDAQ: DRTS) announced completion of patient enrollment in its ReSTART pivotal trial, a U.S. multicenter study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE